The Pathology Network
PrivateLast Round
Accelerator
Jun 14, 2024
Total Funding Raised
$750,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
The Pathology Network is a healthtech company that operates a digital diagnostic management platform, Spes360, to connect hospitals and doctors in Africa with a global network of specialized laboratories and pathologists.
Sector
Healthcare & Life Sciences
Verticals
Revenue Cycle, InsurTech
Business Model
B2B
Customer Profile
Marketplace Commission, Subscription SaaS, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
The Pathology Network Comparables
Compare The Pathology Network with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Healthshare Health Solutions | 64% | |
| Lancet Laboratories | 62% | |
| Ampath | 62% |
The Pathology Network Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 14, 2024 | ||||
| Seed | Jan 1, 2023 | ||||
| Grant | Sep 27, 2022 | ||||
| Seed | Jun 2, 2021 | ||||
| Pre Seed | May 13, 2020 |
The Pathology Network Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HealthTech Hub Africa | Accelerator |
| Villgro Africa | Seed, Pre Seed |
| Jaza Rift Ventures | Seed |
| Kua Ventures | Seed |
| Investing in Innovation (i3) Africa | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 645% MoM, from 185 to 1.4K.
- Jul 30, 2025
Attended the 2nd National Cancer Summit organized by the National Cancer Institute of Kenya.
Recent news
Latest coverage and updates
- partners_withSep 25, 2026
The Pathology Network Ltd partners with Cerba Lancet Kenya Limited.
The Pathology Network Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about The Pathology Network's valuation, stock price, and market status.
Is The Pathology Network a public or private company?
The Pathology Network is a private company.
What is the current stock price of The Pathology Network?
The Pathology Network is a private company with no public stock price. No recent secondary market data is available.
How much is The Pathology Network worth (valuation)?
Valuation information for The Pathology Network is not publicly available.
Can I buy The Pathology Network stock?
The Pathology Network shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was The Pathology Network's last funding round?
The Pathology Network's most recent funding round was Grant on September 27, 2022.
Who are the main investors in The Pathology Network?
Key investors in The Pathology Network include Villgro Africa.
Will The Pathology Network IPO soon?
No public IPO plans have been announced for The Pathology Network.
How can I track The Pathology Network secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor The Pathology Network's secondary market activity and sign up for updates.